Heart patients needed for study

January 08, 2013

Penn State Milton S. Hershey Medical Center’s Dr. Barry Clemson is participating in a research study determining the safety and effectiveness of giving a low molecular weight heparin or placebo to patients who require a temporary interruption of warfarin when having surgery (i.e. bridging anticoagulation). This will help doctors to determine the best way to care for patients in the future.

Volunteers with atrial fibrillation or atrial flutter may be eligible to volunteer for this study.

To participate, volunteers must be 18 years old, taking warfarin for at least 3 months, and have an upcoming surgery or invasive procedure.

Study volunteers will attend clinic visits, participate in telephone follow up, take study medication or placebo and complete a diary.

For more information, call Kim Hitz at 717-531-4924.

This research study has been approved by the Institutional Review Board, under federal regulations at Penn State Hershey Medical Center, Penn State College of Medicine.

(Media Contacts)

Last Updated March 04, 2013